HIV-1 RNA rectal shedding is reduced in men with low plasma HIV-1 RNA viral loads and is not enhanced by sexually transmitted bacterial infections of the rectum

J Infect Dis. 2011 Sep 1;204(5):761-7. doi: 10.1093/infdis/jir400.

Abstract

Background: Among human immunodeficiency virus (HIV)-infected men who have sex with men (MSM) taking combination antiretroviral therapy (cART), the impact of rectal sexually transmitted infections (STIs) on rectal HIV-1 shedding is unknown.

Methods: Human immunodeficiency virus type 1 (HIV-1) RNA was quantified from rectal swabs collected for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT) screening of HIV-1-infected MSM. Correlations of STIs with rectal viral load were explored using multinomial regression modeling. HIV-1 coreceptor tropism was predicted from sequencing in a subset of men.

Results: Thirty-one (39%) of 80 men (59 prescribed combination antiretroviral therapy [cART]) had HIV detected in 38 (42%) of 91 rectal swabs. Rectal HIV detection was associated with plasma virus loads above 3.15 log₁₀ copies/mL (95% confidence limit [CL] 2.73, 3.55) and paired rectal viral loads and plasma viral loads were correlated (Kendall's tau [τ] 0.68, Spearman rho [P] = .77). Rectal STIs and abnormal anal cytology were not associated with rectal viral load. HIV coreceptor distribution was very similar between the plasma and rectum in 3 of 4 men.

Conclusions: Plasma and rectal viral load were correlated, and rectal STIs did not increase the likelihood of detecting HIV in the rectal secretions in MSM, including those with low or undetectable plasma viral load. Suppressing plasma viral load is likely to reduce risk of HIV transmission to insertive partners.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Anti-Retroviral Agents / pharmacology
  • Anus Diseases / pathology
  • Anus Diseases / virology
  • CD4 Lymphocyte Count
  • Chlamydia Infections / complications*
  • Chlamydia trachomatis*
  • Drug Therapy, Combination
  • Gonorrhea / complications*
  • HIV Infections / complications
  • HIV Infections / virology*
  • HIV-1*
  • Homosexuality, Male
  • Humans
  • Male
  • Middle Aged
  • Neisseria gonorrhoeae*
  • RNA, Viral / analysis*
  • RNA, Viral / blood
  • Receptors, CCR5 / analysis
  • Receptors, CCR5 / blood
  • Receptors, CXCR4 / analysis
  • Receptors, CXCR4 / blood
  • Rectum / chemistry
  • Rectum / virology*
  • Regression Analysis
  • Viral Load / drug effects

Substances

  • Anti-Retroviral Agents
  • RNA, Viral
  • Receptors, CCR5
  • Receptors, CXCR4